S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)
Mirtazapine Tablet
Product Images NDC 63629-2368
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 63629-2368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl636292368)
The text is a description of a medication called NILD. It contains Mirtazapine, USP 30 mg and comes in the form of tablets. It is recommended to keep the medication away from children and store it in a tightly sealed container at a temperature of 20° to 25°C (68° to 77°F) as per USP Controlled Room Temperature. This medication appears to require a prescription (Rx only). The NDC (National Drug Code) for the Mirtazapine Tablets, USP is 63629-2368-1.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
